GQRRX
Price
$17.70
Change
+$0.61 (+3.57%)
Updated
Apr 9 closing price
Net Assets
3.24B
NPFCX
Price
$54.57
Change
+$3.98 (+7.87%)
Updated
Apr 9 closing price
Net Assets
132.16B
Ad is loading...

GQRRX vs NPFCX

Header iconGQRRX vs NPFCX Comparison
Open Charts GQRRX vs NPFCXBanner chart's image
GQG Partners Global Quality Equity R6
Price$17.70
Change+$0.61 (+3.57%)
VolumeN/A
Net Assets3.24B
American Funds New Perspective C
Price$54.57
Change+$3.98 (+7.87%)
VolumeN/A
Net Assets132.16B
GQRRX vs NPFCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GQRRX vs. NPFCX commentary
Apr 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GQRRX is a Buy and NPFCX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
NPFCX has more cash in the bank: 132B vs. GQRRX (3.24B). GQRRX pays higher dividends than NPFCX: GQRRX (0.97) vs NPFCX (0.00). GQRRX was incepted earlier than NPFCX: GQRRX (6 years) vs NPFCX (24 years). NPFCX (1.48) is less costly to investors than GQRRX (0.71). GQRRX is a more actively managed with annual turnover of: 97.00 vs. NPFCX (24.00). GQRRX has a lower initial minimum investment than NPFCX: GQRRX (0) vs NPFCX (250). NPFCX annual gain was more profitable for investors over the last year : -10.63 vs. GQRRX (-12.59). GQRRX return over 5 years is better than : 80.36 vs. NPFCX (30.30).
GQRRXNPFCXGQRRX / NPFCX
Total Expense Ratio0.711.4848%
Annual Report Gross Expense Ratio0.711.4848%
Fund Existence6 years24 years-
Gain YTD-8.266-12.62565%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets3.24B132B2%
Annual Yield % from dividends0.970.00-
Returns for 1 year-12.59-10.63118%
Returns for 3 years13.90-7.88-176%
Returns for 5 years80.3630.30265%
Returns for 10 yearsN/A34.66-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GLDD8.810.77
+9.64%
Great Lakes Dredge & Dock Corp
GMAB18.830.85
+4.73%
Genmab A/S ADS
INTR5.260.22
+4.46%
Inter & Co
ALDX1.930.01
+0.78%
Aldeyra Therapeutics
SONN1.25N/A
+0.34%
Sonnet BioTherapeutics Holdings Inc